Deepika Garg, MD, FACOG
Assistant Professor of Obstetrics, Gynecology and Reproductive SciencesCards
About
Research
Publications
2022
Effect of chemotherapy on the uterus of young adult cancer survivors
Garg D, Hodgman M, Reil S, Lomo L, Aston K, Hill J, Johnstone E, Jenkins T, Letourneau J. Effect of chemotherapy on the uterus of young adult cancer survivors. F&S Reports 2022, 3: 198-203. PMID: 36212573, PMCID: PMC9532891, DOI: 10.1016/j.xfre.2022.05.008.Peer-Reviewed Original ResearchEndometrial thicknessChemotherapy exposureEndometrial biopsyUterine volumeCancer survivorsHodgkin's lymphomaMenstrual cycleDeoxyribonucleic acid (DNA) methylation patternsCross-sectional pilot studyYoung adult cancer survivorsImpact of chemotherapyRibonucleic acid expression levelsEffect of chemotherapyAdult cancer survivorsGeneral population controlsLate proliferative phaseMedian uterine volumeUniversity fertility clinicPelvic radiationEndometrial histologyPelvic ultrasoundCervical cancerFalse-positive resultsMenstruating womenStudy visit
2021
Cancer treatment is associated with a measurable decrease in live births in a large, population-based study
Garg D, Meeks H, Johnstone E, Berga S, Smith K, Hotaling J, Letourneau J. Cancer treatment is associated with a measurable decrease in live births in a large, population-based study. F&S Reports 2021, 2: 462-467. PMID: 34934988, PMCID: PMC8655402, DOI: 10.1016/j.xfre.2021.08.004.Peer-Reviewed Original ResearchIncidence rate ratiosPopulation-based studyLive birth rateAge-matched controlsLive birthsCancer survivorsCancer typesHealthy controlsBreast cancerLower live birth ratesCancer treatmentCentral nervous system cancerRetrospective cohort studyFemale cancer patientsNon-cancer controlsNervous system cancersAge 18 yearsCommon cancer typesSoft tissue cancerBirth rateCohort studyGastrointestinal cancerCancer patientsSystem cancersMAIN OUTCOME
2020
Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments
Garg D, Johnstone E, Lomo L, Fair D, Rosen M, Taylor R, Silver B, Letourneau J. Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. Journal Of Assisted Reproduction And Genetics 2020, 37: 1467-1476. PMID: 32342270, PMCID: PMC7311602, DOI: 10.1007/s10815-020-01792-9.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCancer survivorsPregnancy complicationsObstetrical outcomesFertility-preserving treatmentLow birth weightPoor obstetrical outcomesFemale cancer survivorsImpact of chemotherapyEarly pregnancy lossOncofertility carePregnancy implantationLate complicationsPregnancy outcomesPreterm birthRadiation fibrosisEndometrial receptivityGonadotoxic effectsUterine injuryBirth weightPregnancy lossPregnant uterusBlood supplyUterine functionChemotherapyComplicationsChapter 1 Neuroendocrine mechanisms of reproduction
Garg D, Berga SL. Chapter 1 Neuroendocrine mechanisms of reproduction. Handbook Of Clinical Neurology 2020, 171: 3-23. PMID: 32736757, DOI: 10.1016/b978-0-444-64239-4.00001-1.ChaptersConceptsGnRH driveNeuroendocrinology of reproductionReproductive functionFunctional hypothalamic amenorrheaSex steroid hormone synthesisFollicle-stimulating hormoneGonadotropin-releasing hormoneStress-induced anovulationSteroid hormone synthesisAbsence of oocytesHypothalamic amenorrheaHypothalamic hypogonadismCongenital causesCeliac diseaseMenstrual cyclePsychogenic amenorrheaCommon causeGonadal axisEndocrine effectsAnterior pituitaryBrain tumorsBehavioral variablesSecondary insufficiencyAppropriate secretionNeuroendocrine mechanisms
2019
Oncofertility conundrum: discrepancy between anti-Mϋllerian hormone and mature oocyte yield in a peripubertal girl with Hodgkin lymphoma
Garg D, Johnstone E, Fair D, Carrell D, Berga S, Letourneau J. Oncofertility conundrum: discrepancy between anti-Mϋllerian hormone and mature oocyte yield in a peripubertal girl with Hodgkin lymphoma. Journal Of Assisted Reproduction And Genetics 2019, 36: 1753-1756. PMID: 31313012, PMCID: PMC6708038, DOI: 10.1007/s10815-019-01516-8.Peer-Reviewed Original Research
2017
Treatment Modalities for Fibroids, Indications, Risks, and Benefits
Garg D, Segars J. Treatment Modalities for Fibroids, Indications, Risks, and Benefits. 2017, 87-106. DOI: 10.1007/978-3-319-58780-6_3.ChaptersTreatment modalitiesUterine fibroidsGonadotropin-releasing hormone agonistInvasive surgeryInterventional radiological approachAbnormal uterine bleedingTreatment of fibroidsManagement of fibroidsNew treatment optionsSize of fibroidsCommon benign neoplasmInterventional radiological proceduresFibroid managementAbdominal painHormonal therapyUrinary frequencyUterine bleedingProcedural indicationsPressure symptomsAbdominal girthHormone agonistMedical managementPatient's symptomsSurgical managementClinical manifestationsCorrelation between follicular fluid levels of sRAGE and vitamin D in women with PCOS
Garg D, Grazi R, Lambert-Messerlian GM, Merhi Z. Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS. Journal Of Assisted Reproduction And Genetics 2017, 34: 1507-1513. PMID: 28825156, PMCID: PMC5699991, DOI: 10.1007/s10815-017-1011-6.Peer-Reviewed Original ResearchConceptsAdvanced glycation end productsFollicular fluidVitamin DPro-inflammatory advanced glycation end productsHigher anti-Mullerian hormone levelsAnti-Mullerian hormone levelsProtective anti-inflammatory roleFollicular fluid levelsLevels of sRAGEAnti-inflammatory rolePathogenesis of PCOSGlycation end productsPotential therapeutic targetDay 5 embryosConclusionsIn womenSRAGE levelsOvarian dysfunctionOvarian levelHormone levelsPCOSSRAGESoluble receptorTherapeutic targetDay 3Fluid levelsProgesterone-Mediated Non-Classical Signaling
Garg D, Ng S, Baig K, Driggers P, Segars J. Progesterone-Mediated Non-Classical Signaling. Trends In Endocrinology And Metabolism 2017, 28: 656-668. PMID: 28651856, DOI: 10.1016/j.tem.2017.05.006.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsProgesterone response elementGrowth factor signalingNon-genomic signalingNon-classical signaling pathwaysNon-classical signalingCycle regulationFactor signalingSignaling pathwaysResponse elementProgesterone signalingCell growthSignalingProgesterone receptorSubsequent activationNovel therapeutic strategiesHormone actionProgesterone actionPathwayGrowth factorImportant physiological actionsPhysiological actionsMenstrual cycle regulationNuclear progesterone receptorRecent studiesActivation
2016
Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS
Garg D, Merhi Z. Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS. Reproductive Biology And Endocrinology 2016, 14: 71. PMID: 27769286, PMCID: PMC5073880, DOI: 10.1186/s12958-016-0205-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH Keywords3-Hydroxysteroid DehydrogenasesAnimalsCholesterol Side-Chain Cleavage EnzymeFemaleGlycation End Products, AdvancedGonadal Steroid HormonesGranulosa CellsHumansOvaryPhosphoproteinsPolycystic Ovary SyndromeReceptors, LHReceptors, PeptideReceptors, Transforming Growth Factor betaSteroid 17-alpha-HydroxylaseTheca CellsConceptsAdvanced glycation end productsOvaries of womenTheca cell functionGlycation end productsCell functionHormone receptor expressionSteroidogenic enzyme activitiesSteroidogenic acute regulatory proteinAbnormal steroidogenesisPCOS modelOvarian dysfunctionAcute regulatory proteinReceptor expressionPCOSFollicular developmentTheca cellsGranulosa cellsSystematic reviewNew interventionsHormone receptorsEnzyme cytochrome P450SteroidogenesisEnd productsGranulosaCytochrome P450A Comparison of Self-Assessment of Clinical Skills of OBGYNs Trained in Different Eras [7B]
Garg D, Prabakar C, Tang N, Bral P. A Comparison of Self-Assessment of Clinical Skills of OBGYNs Trained in Different Eras [7B]. Obstetrics And Gynecology 2016, 127: 20s. DOI: 10.1097/01.aog.0000483327.67165.1c.Peer-Reviewed Original ResearchPercent of respondentsVaginal hysterectomyForceps deliveryVacuum deliveryPelvic brimAnonymous questionnaire surveyGynecologic proceduresYounger counterpartsOBGYNWork hoursYear of graduationNew physiciansOlder counterpartsClinical skillsPercent of graduatesLess hoursHoursConcurrent increaseTraining programPercentAnnual national meetingNational meetingsSpecialtiesDeliveryHysterectomy
Academic Achievements & Community Involvement
Clinical Care
Overview
Deepika Garg, MD, is a reproductive endocrinology and infertility (REI) specialist who provides individualized, compassionate care tailored to each patient’s goals and needs.
She approaches each patient with deep empathy and a personal commitment to their health care journey. She takes time to listen closely to their stories, understand their unique challenges, and build trust through compassionate, hands-on support every step of the way.
Dr. Garg works closely with patients to craft individualized treatment plans—ranging from intrauterine insemination (IUI) and in vitro fertilization (IVF) to fertility preservation and minimally invasive surgery—for diverse patients facing infertility, polycystic ovary syndrome (PCOS), endometriosis, or recurrent pregnancy loss.
Her patient-centered approach prioritizes evidence-based protocols and close monitoring to optimize outcomes, helping countless couples achieve successful pregnancies. “I blend medical expertise to turn dreams of family into reality,” she says, bringing cultural sensitivity to support every unique story.
Her lifelong passion for REI shines through in every patient interaction, turning medical expertise into deeply personal victories.
Clinical Specialties
Obstetrics, Gynecology & Reproductive Sciences; Reproductive Endocrinology & Infertility
Fact Sheets
In Vitro Fertilization (IVF)
Learn More on Yale MedicineSurrogacy
Learn More on Yale Medicine
Yale Medicine News
Links
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.